Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture.
Ontology highlight
ABSTRACT: Multidrug-resistant bacterial infections are becoming increasingly common, with only few last-resort antibiotics such as colistin available for clinical therapy. An alternative therapeutic strategy gaining momentum is phage therapy, which has the advantage of not being affected by bacterial resistance to antibiotics. However, a major challenge in phage therapy is the rapid emergence of phage-resistant bacteria. In this work, our main aim was to understand the mechanisms of phage-resistance used by the top priority pathogen Acinetobacter baumannii. We isolated the novel phage Phab24, capable of infecting colistin-sensitive and -resistant strains of A. baumannii. After co-incubating Phab24 with its hosts, we obtained phage-resistant mutants which were characterized on both geno
SUBMITTER: Wang X
PROVIDER: S-EPMC8648044 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA